Ionic remodeling in the heart: Pathophysiological significance and new therapeutic opportunities for atrial fibrillation

Circulation Research

Volumn 87, Issue 6, 2000, Pages 440-447

  Nattel, Stanley ^a,b,c   Li, Danshi ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Cardiac electrophysiology; Congestive heart failure; Heart arrhythmia mechanisms; Heart disease; Ion channels

Indexed keywords

DOFETILIDE; ION CHANNEL; MIBEFRADIL;

CONGESTIVE HEART FAILURE; DRUG RESPONSE; EXPERIMENTAL MODEL; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

EID: 0034665058     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.6.440     Document Type: Review

References (92)

1. Studies in congestive heart failure, IV: Potassium content of skeletal and cardiac muscle
2. Excitability and electrical activity of human myocardial strips from the left atrial appendage in cases of rheumatic mitral stenosis
3. Electrophysiological study of human heart muscle
4. Depressed transmembrane potentials during experimentally induced ventricular failure in cats
5. Possible electrophysiological basis for decreased contractility associated with myocardial hypertrophy in the cat: A voltage clamp approach
6. Cardiac hypertrophy and altered cellular electrical activity of the myocardium: Possible electrophysiologic basis for myocardial contractility changes
7. Electrophysiological remodeling in hypertrophy and heart failure
8. Electrical remodeling in ischemia and infarction
9. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
10. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation
11. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation
12. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model
13. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation
14. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: Insights from a mathematical model
15. Mathematical analysis of canine atrial action potentials: Rate, regional factors and electrical remodeling
16. + current in a chronic dog model of atrial fibrillation
17. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia
18. Steady-state and nonsteady-state action potentials in fibrillating canine atrium: Abnormal rate adaptation and its possible mechanisms
19. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin43 in dogs
20. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat
21. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat
22. Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation
23. Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40
24. The effects on atrial electrophysiology and structure of surgically induced fight atrial enlargement in dogs
25. Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis
26. Mechanisms for atrial arrhythmias associated with cardiomyopathy: A study of feline hearts with primary myocardial disease
27. Effects of experimental heart failure on atrial cellular and ionic electrophysiology
28. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation
29. The effect of altered thyroid state on atrial intracellular potentials
30. Thyroxine effects on temperature dependence of ionic currents in single rabbit cardiac myocytes
31. Hyperthyroidism selectively modified a transient potassium current in rabbit ventricular and atrial myocytes
32. Effects of thyroid hormone on the action potential and membrane currents of guinea pig ventricular myocytes
33. 2+ current in guinea pig ventricular myocytes
34. 2+ channels in patients with latent hyperthyroidism
35. Electrophysiologic properties and response to pharmacologic agents of fibers from diseased human atria
36. Electrophysiological properties of diseased human atrium, I: Low diastolic potential and altered cellular response to potassium
37. Factors related to the low resting membrane potentials of diseased human atrial muscles
38. + channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts
39. Depressed transient outward and calcium currents in dilated human atria
40. Transient outward current in young and adult diseased human atria
41. + current similar to Kv1.5 cloned channel currents
42. + current in cultured adult human atrial myocytes
43. Calcium currents in diseased human cardiac cells
44. Comparison of calcium-current in isolated atrial myocytes from failing and nonfailing human hearts
45. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation
46. Ionic mechanisms of electrical remodeling in human atrial fibrillation
47. 2+ currents and human atrial fibrillation
48. Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation
49. Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atrium
50. Altered transient outward current in human atrial myocytes of patients with reduced left ventricular function
51. Calcium handling proteins in the failing human heart
52. Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation
53. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation
54. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling
55. 2+ channel in persistent atrial fibrillation in humans
56. Dihydropyridine and β adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation
57. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644
58. Electrical remodeling in atrial fibrillation: Time course and mechanisms
59. Tachycardia-induced change of atrial refractory period in humans: Rate dependency and effects of antiarrhythmic drags
60. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans
61. Ionic mechanisms underlying human atrial action potential properties: Insights from a mathematical model
62. Verapamil reduces tachycardia-induced electrical remodeling of the atria
63. Comparative study of the efficacy of T-and L-type calcium channel blockers against atrial remodeling due to sustained atrial tachycardia
64. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling
65. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs
66. 2+ channels and pharmacological blockade: Potential pathophysiological relevance
67. + channels I(Kr) and I(Ks)
68. Clinical pharmacokinetics of mibefradil
69. + exchanger in short-term atrial electrophysiological remodeling
70. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
71. Atrial electrophysiological remodeling caused by rapid atrial activation: Underlying mechanisms and clinical relevance to atrial fibrillation
72. + channels in rat atrium: Electrical remodeling in paroxysmal atrial tachycardia
73. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure
74. Decrease in delayed rectifier currents (I(Kr) and I(Ks)) in addition to decrease in I(Ca)-L and I(to) in rabbits with pacing-induced heart failure
75. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts
76. Myocytes electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy
77. Ionic basis of the action potential prolongation in ventricular myocytes from Syrian hamsters with dilated cardiomyopathy
78. 2+ homeostasis in rabbits with pacing-induced heart failure
79. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure
80. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: Experimental studies
81. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia induced atrial electrical remodeling
82. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria?
83. The role of atrial electrical remodeling in the progression of focal atrial ectopy to persistent atrial fibrillation
84. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography
85. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort
86. Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation
87. Atrial tachycardia in dogs with ventricular pacing-induced congestive heart failure originates from multiple foci in the crista terminalis and pulmonary veins: Experimental evidence supporting the 'atrial ring of fire' hypothesis
88. 2+ exchange to action potential of human atrial myocytes
89. Acquired delayed rectifier channelopathies: How heart disease and antiarrhythmic drugs mimic potentially-lethal congenital cardiac disorders
90. 2+-exchanger protein levels and diastolic function of failing human myocardium
91. 2+] rat ventricular myocytes following myocardial infarction
92. + channel subunit in the mouse heart